43
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T9967 |
MAGL-IN-5
|
Lipid | Metabolism |
MAGL-IN-5 是一种非选择性脂肪酶抑制剂。 | |||
T9687 |
MAGL-IN-4
His121 ARG57 |
Lipase | Metabolism |
MAGL-IN-4 (His121 ARG57) 是选择性的、口服有效的、可透过血脑屏障的、可逆的单酰基甘油脂肪酶抑制剂,IC50=6.2 nM。它主要通过大脑中选择性抑制 MAGL 增加 2-花生四烯酰甘油水平来增强内源性大麻素信号。 | |||
T11939 |
MAGL-IN-1
|
Lipase | Metabolism |
MAGL-IN-1 is a selective and potent monoacylglycerol lipase (MAGL) inhibitor with an IC50 of 80 nM. | |||
T81879 | MAGL-IN-8 | MAGL | Metabolism |
MAGL-IN-8 (compound 13) 是一种针对 hMAGL 的高选择性可逆抑制剂,其IC50值为2.5 ± 0.4 nM。 | |||
T81880 | MAGL-IN-11 | MAGL | Metabolism |
MAGL-IN-11(化合物 29),一种选择性且可逆的MAGL抑制剂,具备研究炎症、癌症和抗氧化潜力。 | |||
T81881 | MAGL-IN-10 | MAGL | Metabolism |
MAGL-IN-10为一种可逆MAGL抑制剂,展现出优良的ADME特性且体内毒性低。该化合物适用于癌症、神经系统疾病和炎症病理学研究。 | |||
T62489 | MAGL-IN-6 | ||
MAGL-IN-6是一种 MAGL 的有效抑制剂 (IC50: 4.71 nM)。MAGL-IN-6 能够用于研究神经系统疾病。 | |||
T81878 | MAGL-IN-9 | MAGL | Metabolism |
MAGL-IN-9 (compound 16)为高选择性、可逆MAGL抑制剂,其IC50值为2.7 nM[1]< /sup >。 | |||
T61198 | FAAH/MAGL-IN-1 | ||
FAAH/MAGL-IN-1, also known as compound SIH 3, is a highly effective inhibitor of FAAH (fatty acid amide hydrolase) and MAGL (monoacylglycerol lipase). It exhibits IC50 values of 31 nM and 29 nM against FAAH and MAGL, respectively. This compound shows promising potential for advancing research in the field of neuropathic pain [1]. | |||
T61707 |
FAAH/MAGL-IN-2
|
||
FAAH/MAGL-IN-2 是一种有效的,可逆的,具有口服活性且可透过血脑屏障的 FAAH 和 MAGL 抑制剂,其IC50值分别为 11 nM 和 36 nM (b>Ki 值分别为 28 nM 和 60 nM)。FAAH/MAGL-IN-2 有研究神经性疼痛的潜力而不引起运动障碍。 | |||
T15632 |
JW 642
|
Lipase | Metabolism |
JW 642 是一种高效的MAGL 抑制剂,对小鼠、大鼠和人源脑细胞膜上MAGL 的IC50值分别为7.6nM、14nM 和3.7nM。 | |||
T62671 | FAAH/MAGL-IN-3 | ||
FAAH/MAGL-IN-3 (Compound 10) 是一种不可逆的脂肪酸酰胺水解酶 (FAAH)和单酰基甘油脂酶 (MAGL)双重抑制剂,能够作用于 FAAH (IC50: 179 nM) 和 MAGL (IC50: 759 nM)。FAAH/MAGL-IN-3 表现出很小的 PAMPA (平行人工膜渗透性试验) 透过性。 | |||
T15614 |
JJKK 048
|
Lipase | Metabolism |
JJKK 048 是一种有效的特异性 MAGL 抑制剂。 | |||
T5353 |
ABX-1431
Elcubragistat |
Lipase | Metabolism |
ABX-1431 (Elcubragistat) 是口服具有活力的、选择性CNS-渗透性单酰基甘油脂肪酶抑制剂,IC50=14 nM。 | |||
T8974 |
ML-211
|
Others | Others |
ML-211 是基于氨基甲酸酯的酰基蛋白硫酯酶1 / 溶血磷脂酶1 (IC50=17 nM) 和LYPLA2(IC50=30 nM) 的双重抑制剂。它能够抑制丝氨酸水解酶ABHD11 (IC50=10 nM),但在 20 个丝氨酸水解酶组合中,对 LYPLA 的选择性为 50 倍。 | |||
T17260 |
WWL70
|
Lipase; MAGL | Metabolism |
WWL70 是选择性 α/β 水解酶结构域 6 抑制剂,其IC50=70 nM。 | |||
T15635 |
JZP-430
|
Lipase; MAGL | Metabolism |
JZP-430 是不可逆的、高度选择性的 α/β 水解酶结构域 6 抑制剂,能够靶向抑制人类 ABHD6 ,其 IC50=44 nM。 | |||
T6554 |
JZL 184
JZL184 |
Lipase | Metabolism |
JZL 184 是不可逆的、选择性的MAGL 抑制剂,对MAGL 的选择性比 FAAH 高 300 倍以上。它可阻断脑膜中的 2-花生四烯酸甘油酯 (2-AG) 的水解 (IC50为 8 nM)。 | |||
T2338 |
JZL195
|
FAAH; Lipase; Autophagy | Autophagy; Metabolism; Neuroscience |
JZL195 是一种选择性有效的脂肪酸酰胺水解酶和单酰甘油脂肪酶双重抑制剂,IC50s 分别为 2 和 4 nM。 | |||
T4052 |
KML29
|
Lipase | Metabolism |
KML29 是一种口服具有活性的、高度选择性的不可逆 MAGL 抑制剂,其对小鼠、大鼠和人的 IC50值分别为15 nM、43 nM 和 5.9 nM。它对 FAAH 在内的其他中心和外周丝氨酸水解酶的交叉反应极小。 | |||
T5815 |
MJN110
Cravatt Reagent |
Lipase | Metabolism |
MJN110 (Cravatt Reagent) 是选择性的、口服具有活性的单酰基甘油脂肪酶 (MAGL) 抑制剂,对 hMAGL 和 2-花生四烯酸甘油酯 (2-AG) 的IC50分别为 9.1 nM 和 2.1 nM。它具有阿片类药物保护作用,具有显著的抗痛觉过敏活性。 | |||
T8994 |
ML-226
ML226,ML-226 |
MAGL | Metabolism |
ML226 是 α/β hydrolase domain-containing protein 11 抑制剂,体外和原位的 IC50s 分别为 15 和 0.68 nM。 | |||
T9374 |
AA38-3
1-Piperidinecarboxylic acid, 4-nitrophenyl ester |
FAAH; Lipase; MAGL | Metabolism; Neuroscience |
AA38-3 (1-Piperidinecarboxylic acid, 4-nitrophenyl ester) 是丝氨酸水解酶抑制剂,能够抑制三种 SHs:ABHD6,ABHD11 和 FAAH。 | |||
T19850L |
Semaglutide Acetate
索玛鲁肽醋酸盐,Semaglutide Acetate(910463-68-2 Free base) |
Glucagon Receptor | GPCR/G Protein |
Semaglutide Acetate 是胰高血糖素样肽 1 (GLP-1) 受体的激动剂,可用于治疗 2 型糖尿病的研究。 | |||
T61972 |
Pomaglumetad methionil hydrochloride
LY2140023 hydrochloride |
GluR | Neuroscience |
Pomaglumetad methionil hydrochloride (LY2140023 hydrochloride) (LY2140023 hydrochloride) 是的 LY404039 的蛋氨酸前药,具有口服活性。LY404039是一种选择性 mGlu2/3 受体激动剂。Pomaglumetad methionil hydrochloride 可用于精神分裂症的研究。 | |||
T19850 |
Semaglutide
索玛鲁肽,司美格鲁肽,索马鲁肽 |
Glucagon Receptor | GPCR/G Protein |
Semaglutide 是人胰高血糖素样肽-1受体激动剂,是一种人胰高血糖素样肽-1 的长效类似物。它有用于 2 型糖尿病研究的潜力。 | |||
T62937 |
MAGLi 432
|
||
MAGLi 432 是一种有效的、高度选择性的、非共价的、可逆的 (MAGL) 抑制剂。MAGLi 432 能够高亲和力的结合 MAGL 活性位点,其 IC50 值为 4.2 nM (human enzyme) 和 3.1 nM (mouse enzyme)。MAGLi 432 能够用于研究慢性炎症、多发性硬化症、血脑屏障功能障碍、阿尔茨海默病和帕金森病等神经系统疾病。 | |||
T12878 |
Semaglutide TFA (910463-68-2 free base)
Semaglutide TFA |
Glucagon Receptor | GPCR/G Protein |
Semaglutide TFA is a agonist of glucagon-like peptide-1 (GLP-1) receptor,with a potential for type 2 diabetes treatment. | |||
T11907 |
Pomaglumetad methionil anhydrous
LY2140023 |
GluR | Neuroscience |
LY2140023 has the potential for schizophrenia.LY2140023 is an orally active prodrug of LY404039. LY404039 is a selective metabotropic glutamate 2/3 receptor agonist. | |||
T12520 |
Pomaglumetad methionil
LY2140023 hydrate |
GluR | Neuroscience |
Pomaglumetad methionil is an oral methionine prodrug of the potent specific agonist of mGlu2/3 receptor LY404039. | |||
T80879 | Vamagloxistat | ||
Vamagloxistat,一种乙醇酸氧化酶抑制剂,旨在治疗高草酸尿症及预防肾结石。 | |||
T69191 |
Pemaglitazar
|
||
Pemaglitazar is a dual peroxisome proliferator-activated receptor (PPAR) alpha and gamma agonist, with hypoglycemic activity. | |||
T27703 |
JZP-361
JZP361,JZP 361 |
Lipase | Metabolism |
JZP-361 是一种特异性 MAGL 抑制剂,对人重组 MAGL、人重组 FAAH 和人 hABHD6 的 IC50 分别为 46 nM、7.24 μM 和 1.79 μM。 JZP-361 具有抗组胺活性。 JZP-361可用于哮喘研究。 | |||
T11724 |
JNJ-42226314
|
Lipase | Metabolism |
JNJ-42226314 是一种具有高选择性的非共价单酰基甘油脂肪酶 (MAGL) 抑制剂,具有抗伤害作用。JNJ-42226314 通过内源性大麻素-2-丙烯酰甘油(2-AG)在神经病理性疼痛和炎症性疼痛模型中显示出疗效。 | |||
T16496 | PF-06795071 | Lipase | Metabolism |
PF-06795071 is an effective and selective covalent inhibitor of MAGL (IC50: 3 nM). | |||
T24758 |
SAR127303
SAR-127303,SAR 127303 |
||
SAR127303 is an effective covalent inhibitor of MAGL. SAR127303 behaves as a selective and competitive inhibitor of mouse and human MAGL. | |||
T37374 |
URB754
|
||
URB754 is a potent and noncompetitive inhibitor of monoacylglycerol lipase (MAGL), exhibiting an IC50 value of 200 nM for the recombinant rat brain enzyme. However, it does not inhibit human recombinant, rat brain, or mouse brain MAGL at concentrations up to 100 μM. There is evidence that the MAGL inhibitory activity of URB754 may be attributed to the impurity bis(methylthio)mercurane (IC50 = 11.9 nM for rat recombinant MAGL) that is found in commercial preparations. URB754 inhibits rat brain fa... | |||
T21905 | N-Arachidonyl Maleimide | ||
N-Arachidonyl maleimide 是一种有效且不可逆的单酰基甘油脂肪酶 (MAGL) 抑制剂,IC50值为 140 nM。 | |||
T28235 |
OMDM169
OMDM 169,OMDM-169 |
||
OMDM169 is a potent and selective MAGL inhibitor. OMDM169 could enhances 2-AG levels and of exerts analgesic activity via indirect activation of cannabinoid receptors. OMDM169 exhibited 0.13 microM<IC(50)<0.41 microM towards 2-AG hydrolysing activities in | |||
T37629 |
IDFP
|
||
The endocannabinoids, 2-arachidonoyl glycerol (2-AG) and arachidonoyl ethanolamide (AEA), are biologically active lipids that regulate diverse neurological and metabolic functions by activating the cannabinoid receptors, central cannabinoid (CB1) and peripheral cannabinoid (CB2). Monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH) hydrolyze 2-AG and AEA, respectively, thus terminating their biological function. IDFP is an organophosphorus compound that dually inhibits MAGL and F... | |||
T36498 |
CAY10762
CAY10762 |
||
CAY10762 is an inhibitor of monoacylglycerol lipase (MAGL; IC50= 34.1 nM).1It reduces hydrogen peroxide-induced lactate dehydrogenase (LDH) release from Neuro2a cells when used at a concentration of 1 μM. CAY10762 (10 mg/kg) increases levels of 2-arachidonoyl glycerol in mouse brain. 1.Castelli, R., Scalvini, L., Vacondio, F., et al.Benzisothiazolinone derivatives as potent allosteric monoacylglycerol lipase inhibitors that functionally mimic sulfenylation of regulatory cysteinesJ. Med. Chem.63(... | |||
T73317 |
JZP-MA-13
|
||
JZP-MA-13是一种选择性α/β-水解酶结构域6 (ABHD6) 抑制剂,其IC50值为392 nM。该化合物对MAGL、ABHD12、FAAH或其它丝氨酸水解酶不表现出抑制作用。JZP-MA-13还被用作ABHD6在体内成像的正电子发射断层扫描(PET)配体。 | |||
T12826 |
SA57
|
FAAH | Metabolism; Neuroscience |
SA57 is a potent, selective inhibitor of FAAH(IC50s of 3.2 nM and 1.9 nM for mouse and human FAAH). |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T5737 |
euphol
|
Others; Lipase; Endogenous Metabolite | Metabolism; Others |
Euphol 是从Euphorbia tirucalli 的汁液中分离出来的四环三萜醇,具有抗炎和免疫调节作用,口服具有活力。 它通过能够逆机制抑制单酰基甘油脂肪酶 (MGL) 的特性,IC50=315 nM。 外周 MGL 抑制能够调节内源性大麻素系统从而阻止炎症性疼痛的发展。 | |||
TN4904 | Rehmaglutin D | Others | Others |
Rehmaglutin D是一种天然产物,属于苦木科臭椿属,其产品编号为 TN4904,CAS号为 103744-84-9。Rehmaglutin D可用作对照参考。 | |||
TN5409 |
Maglifloenone
Denudatone |
||
Maglifloenone是一种天然产物,属于木兰科木兰属,其产品编号为 TN5409,CAS号为 82427-77-8。Maglifloenone可用作对照参考。 |